CN103881723A - 银掺杂硒化锌量子点、其制备方法及应用 - Google Patents
银掺杂硒化锌量子点、其制备方法及应用 Download PDFInfo
- Publication number
- CN103881723A CN103881723A CN201210558813.3A CN201210558813A CN103881723A CN 103881723 A CN103881723 A CN 103881723A CN 201210558813 A CN201210558813 A CN 201210558813A CN 103881723 A CN103881723 A CN 103881723A
- Authority
- CN
- China
- Prior art keywords
- silver
- zinc
- quantum dot
- water
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002096 quantum dot Substances 0.000 title claims abstract description 77
- PFNQVRZLDWYSCW-UHFFFAOYSA-N (fluoren-9-ylideneamino) n-naphthalen-1-ylcarbamate Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1=NOC(=O)NC1=CC=CC2=CC=CC=C12 PFNQVRZLDWYSCW-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 229910052709 silver Inorganic materials 0.000 claims abstract description 30
- 239000004332 silver Substances 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- -1 silver ions Chemical class 0.000 claims abstract description 4
- 239000002243 precursor Substances 0.000 claims description 42
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 16
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical group [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 16
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical group [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 claims description 16
- 230000002829 reductive effect Effects 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 150000003751 zinc Chemical class 0.000 claims description 13
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 12
- 238000003384 imaging method Methods 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical group [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 8
- 229940000207 selenious acid Drugs 0.000 claims description 8
- MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 claims description 8
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 8
- 239000012279 sodium borohydride Substances 0.000 claims description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 8
- 229960001471 sodium selenite Drugs 0.000 claims description 8
- 239000011781 sodium selenite Substances 0.000 claims description 8
- 235000015921 sodium selenite Nutrition 0.000 claims description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 claims description 6
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 claims description 6
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000006862 quantum yield reaction Methods 0.000 claims description 5
- IYKVLICPFCEZOF-UHFFFAOYSA-N selenourea Chemical compound NC(N)=[Se] IYKVLICPFCEZOF-UHFFFAOYSA-N 0.000 claims description 5
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims description 5
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 claims description 5
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 5
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 5
- 229960001763 zinc sulfate Drugs 0.000 claims description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 3
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 3
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 claims description 3
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 claims description 3
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 3
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 3
- 239000012448 Lithium borohydride Substances 0.000 claims description 3
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 3
- 229960004308 acetylcysteine Drugs 0.000 claims description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 3
- FLLNLJJKHKZKMB-UHFFFAOYSA-N boron;tetramethylazanium Chemical compound [B].C[N+](C)(C)C FLLNLJJKHKZKMB-UHFFFAOYSA-N 0.000 claims description 3
- WODNKMACFGPSCV-UHFFFAOYSA-N copper;selenous acid Chemical compound [Cu].O[Se](O)=O WODNKMACFGPSCV-UHFFFAOYSA-N 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims description 3
- 229940116901 diethyldithiocarbamate Drugs 0.000 claims description 3
- LMBWSYZSUOEYSN-UHFFFAOYSA-N diethyldithiocarbamic acid Chemical compound CCN(CC)C(S)=S LMBWSYZSUOEYSN-UHFFFAOYSA-N 0.000 claims description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 235000019136 lipoic acid Nutrition 0.000 claims description 3
- 229960003151 mercaptamine Drugs 0.000 claims description 3
- TXLIUAKKTUQLOR-UHFFFAOYSA-N pentane-2,3-dione silver Chemical compound C(C)C(=O)C(=O)C.[Ag] TXLIUAKKTUQLOR-UHFFFAOYSA-N 0.000 claims description 3
- 229940071536 silver acetate Drugs 0.000 claims description 3
- 229910001958 silver carbonate Inorganic materials 0.000 claims description 3
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 claims description 3
- SDLBJIZEEMKQKY-UHFFFAOYSA-M silver chlorate Chemical compound [Ag+].[O-]Cl(=O)=O SDLBJIZEEMKQKY-UHFFFAOYSA-M 0.000 claims description 3
- 229940071575 silver citrate Drugs 0.000 claims description 3
- 239000011655 sodium selenate Substances 0.000 claims description 3
- 229960001881 sodium selenate Drugs 0.000 claims description 3
- 235000018716 sodium selenate Nutrition 0.000 claims description 3
- 229960002663 thioctic acid Drugs 0.000 claims description 3
- QUTYHQJYVDNJJA-UHFFFAOYSA-K trisilver;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ag+].[Ag+].[Ag+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QUTYHQJYVDNJJA-UHFFFAOYSA-K 0.000 claims description 3
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 239000004246 zinc acetate Substances 0.000 claims description 3
- 229940102001 zinc bromide Drugs 0.000 claims description 3
- 239000011746 zinc citrate Substances 0.000 claims description 3
- 235000006076 zinc citrate Nutrition 0.000 claims description 3
- 229940068475 zinc citrate Drugs 0.000 claims description 3
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 claims description 3
- 229910000165 zinc phosphate Inorganic materials 0.000 claims description 3
- ZPEJZWGMHAKWNL-UHFFFAOYSA-L zinc;oxalate Chemical compound [Zn+2].[O-]C(=O)C([O-])=O ZPEJZWGMHAKWNL-UHFFFAOYSA-L 0.000 claims description 3
- 125000003748 selenium group Chemical class *[Se]* 0.000 claims 4
- 229910052793 cadmium Inorganic materials 0.000 abstract description 5
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 abstract description 5
- 238000001308 synthesis method Methods 0.000 abstract description 5
- 230000006911 nucleation Effects 0.000 abstract description 4
- 238000010899 nucleation Methods 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 3
- 229910052738 indium Inorganic materials 0.000 abstract description 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000011503 in vivo imaging Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 42
- 150000003342 selenium Chemical class 0.000 description 14
- 229910021642 ultra pure water Inorganic materials 0.000 description 10
- 239000012498 ultrapure water Substances 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000011669 selenium Substances 0.000 description 7
- 229910052711 selenium Inorganic materials 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229940091258 selenium supplement Drugs 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000012071 phase Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 125000002524 organometallic group Chemical group 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229910052946 acanthite Inorganic materials 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960004657 indocyanine green Drugs 0.000 description 2
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 2
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229940056910 silver sulfide Drugs 0.000 description 2
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QTEVYKMUKYTEAF-UHFFFAOYSA-N [Se-2].[Zn+2].[Ag+] Chemical compound [Se-2].[Zn+2].[Ag+] QTEVYKMUKYTEAF-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- LCUOIYYHNRBAFS-UHFFFAOYSA-N copper;sulfanylideneindium Chemical compound [Cu].[In]=S LCUOIYYHNRBAFS-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- KDSXXMBJKHQCAA-UHFFFAOYSA-N disilver;selenium(2-) Chemical compound [Se-2].[Ag+].[Ag+] KDSXXMBJKHQCAA-UHFFFAOYSA-N 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Landscapes
- Luminescent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210558813.3A CN103881723B (zh) | 2012-12-20 | 2012-12-20 | 银掺杂硒化锌量子点、其制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210558813.3A CN103881723B (zh) | 2012-12-20 | 2012-12-20 | 银掺杂硒化锌量子点、其制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103881723A true CN103881723A (zh) | 2014-06-25 |
CN103881723B CN103881723B (zh) | 2017-06-13 |
Family
ID=50950865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210558813.3A Active CN103881723B (zh) | 2012-12-20 | 2012-12-20 | 银掺杂硒化锌量子点、其制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103881723B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105542772A (zh) * | 2015-12-22 | 2016-05-04 | 武汉大学 | 一种水溶性过渡金属掺杂ZnSe量子点的合成方法 |
CN113436890A (zh) * | 2021-06-29 | 2021-09-24 | 电子科技大学长三角研究院(湖州) | 一种环保型锌银铟硒量子点敏化的掺杂光阳极及其制备方法与光电化学电池 |
CN114506824A (zh) * | 2021-12-02 | 2022-05-17 | 佛山市铁人环保科技有限公司 | 一种硒化锌溶胶及其制备方法和应用 |
WO2022156467A1 (zh) * | 2021-01-20 | 2022-07-28 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种荧光量子点及其制备方法与应用 |
US11566176B2 (en) | 2019-04-19 | 2023-01-31 | Samsung Electronics Co., Ltd. | Semiconductor nanocrystal particles and devices including the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008133598A1 (en) * | 2007-04-30 | 2008-11-06 | Agency For Science, Technology And Research | Forming crosslinked-glutathione on nanostructure |
WO2009099397A1 (en) * | 2008-02-04 | 2009-08-13 | Agency For Science, Technology And Research | Forming glutathione-capped and metal-doped zinc selenide/zinc sulfide core-shell quantum dots in aqueous solution |
-
2012
- 2012-12-20 CN CN201210558813.3A patent/CN103881723B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008133598A1 (en) * | 2007-04-30 | 2008-11-06 | Agency For Science, Technology And Research | Forming crosslinked-glutathione on nanostructure |
WO2009099397A1 (en) * | 2008-02-04 | 2009-08-13 | Agency For Science, Technology And Research | Forming glutathione-capped and metal-doped zinc selenide/zinc sulfide core-shell quantum dots in aqueous solution |
Non-Patent Citations (1)
Title |
---|
李舒艳: "半导体量子点的水相合成及分析应用研究", 《中国优秀硕士学位论文全文数据库工程科技I辑》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105542772A (zh) * | 2015-12-22 | 2016-05-04 | 武汉大学 | 一种水溶性过渡金属掺杂ZnSe量子点的合成方法 |
US11566176B2 (en) | 2019-04-19 | 2023-01-31 | Samsung Electronics Co., Ltd. | Semiconductor nanocrystal particles and devices including the same |
WO2022156467A1 (zh) * | 2021-01-20 | 2022-07-28 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种荧光量子点及其制备方法与应用 |
CN113436890A (zh) * | 2021-06-29 | 2021-09-24 | 电子科技大学长三角研究院(湖州) | 一种环保型锌银铟硒量子点敏化的掺杂光阳极及其制备方法与光电化学电池 |
CN113436890B (zh) * | 2021-06-29 | 2022-08-30 | 电子科技大学长三角研究院(湖州) | 一种环保型锌银铟硒量子点敏化的掺杂光阳极及其制备方法与光电化学电池 |
CN114506824A (zh) * | 2021-12-02 | 2022-05-17 | 佛山市铁人环保科技有限公司 | 一种硒化锌溶胶及其制备方法和应用 |
CN114506824B (zh) * | 2021-12-02 | 2023-09-05 | 佛山市铁人环保科技有限公司 | 一种硒化锌溶胶及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103881723B (zh) | 2017-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sung et al. | Highly sensitive and selective sensor based on silica-coated CdSe/ZnS nanoparticles for Cu2+ ion detection | |
Zhang et al. | Exploring heterostructured upconversion nanoparticles: from rational engineering to diverse applications | |
Chen et al. | Recent advances in the synthesis and application of Yb-based fluoride upconversion nanoparticles | |
Sun et al. | Paradigms and challenges for bioapplication of rare earth upconversion luminescent nanoparticles: small size and tunable emission/excitation spectra | |
Lv et al. | Dopamine-mediated photothermal theranostics combined with up-conversion platform under near infrared light | |
Wang et al. | ‘Green’-synthesized near-infrared PbS quantum dots with silica–PEG dual-layer coating: ultrastable and biocompatible optical probes for in vivo animal imaging | |
CN103881723A (zh) | 银掺杂硒化锌量子点、其制备方法及应用 | |
Rafique et al. | Morphological evolution of upconversion nanoparticles and their biomedical signal generation | |
Wang et al. | Spectral engineering of lanthanide-doped upconversion nanoparticles and their biosensing applications | |
Runowski et al. | Synthesis and organic surface modification of luminescent, lanthanide-doped core/shell nanomaterials (LnF3@ SiO2@ NH2@ organic acid) for potential bioapplications: spectroscopic, structural, and in vitro cytotoxicity evaluation | |
CN102277157A (zh) | 近红外硫化银量子点、其制备方法及其应用 | |
Zhu et al. | Zn3Ga2Ge2O10: Cr3+ uniform microspheres: template-free synthesis, tunable bandgap/trap depth, and in vivo rechargeable near-infrared-persistent luminescence | |
Liu et al. | Fluorescence quenching between unbonded graphene quantum dots and gold nanoparticles upon simple mixing | |
AU2021102201A4 (en) | Polydopamine-platinum granular nanomaterial doped with moo2 and preparation method thereof | |
Gao et al. | Zinc germanate nanophosphors with persistent luminescence for multi-mode imaging of latent fingerprints | |
CN102031106B (zh) | 一种量子点及其制备方法 | |
Liang et al. | High-performance formaldehyde sensing using paper-based fluorescent copper nanoclusters | |
Szczeszak et al. | Synthesis, photophysical analysis, and in vitro cytotoxicity assessment of the multifunctional (magnetic and luminescent) core@ shell nanomaterial based on lanthanide-doped orthovanadates | |
Chakraborty et al. | Shell-isolated assembly of atomically precise nanoclusters on gold nanorods for integrated plasmonic-luminescent nanocomposites | |
Sun et al. | Upconversion nanoparticles/carbon dots (UCNPs@ CDs) composite for simultaneous detection and speciation of divalent and trivalent iron ions | |
Serge-Correales et al. | Size Control and Improved Aqueous Colloidal Stability of Surface-Functionalized ZnGa2O4: Cr3+ Bright Persistent Luminescent Nanoparticles | |
Chen et al. | Magnetically controllable dual-mode nanoprobes for cell imaging with an onion-liked structure | |
Cui et al. | Core–Shell NaHoF4@ TiO2 NPs: A Labeling Method to Trace Engineered Nanomaterials of Ubiquitous Elements in the Environment | |
Yang et al. | Recent progresses in NIR-II Luminescent bio/chemo sensors based on lanthanide nanocrystals | |
Vijayaraj et al. | Fluorescence imaging of onion epidermal cell utilizing highly luminescent water-soluble CdTe colloidal quantum dots |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240301 Address after: 519085 101, Building 5, Longyuan Smart Industrial Park, No. 2, Hagongda Road, Tangjiawan Town, High-tech Zone, Zhuhai City, Guangdong Province Patentee after: ZHUHAI INSTITUTE OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES Co.,Ltd. Country or region after: China Address before: 1068 No. 518055 Guangdong city in Shenzhen Province, Nanshan District City Xili University School Avenue Patentee before: SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY Country or region before: China |